Healthcare act affirmed; Synapse adds jobs in Ohio; Efficiencies drive GSK inhaler plant;

> In a surprise decision, the Supreme Court has upheld the affordable healthcare act. Story

> Devicemaker Synapse Biomedical is using a $5.1 million state tax break to add 60 jobs to its Oberlin, OH, plant. Story

> Six workers can now handle four assembly lines that turn out 220,000 inhalers a day because of efficiencies built into GlaxoSmithKline's ($GSK) respiratory-drug plant in Ware, England. Story

> Suzhou Pharma will open a quality assurance operation in Lyndhurst, NJ, in an effort to marry Western cGMP know-how with Asian production expertise. Story

And Finally... The FDA user fee law bans 28 chemicals sold at corner stores as hygiene products, incense or plant food that are often used in synthetic drugs known as "bath salts." Story

Suggested Articles

Colorado is making a play for a Japanese CDMO in hopes it will invest about $100 million in an empty AstraZeneca plant in Boulder.

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.